Mayne Pharma Group Limited
OTC: MAYNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Aaron Gray
- Employees
- 450
- Headquarters
- Salisbury South, Australia
- IPO year
- 2013
- Market cap
- $134.1M
- Website
- https://www.maynepharma.com
Loading MAYNF…
Loading profile data…Frequently asked questions about MAYNF
What does Mayne Pharma Group Limited (MAYNF) do?
Mayne Pharma Group Limited is an Australian-headquartered specialty pharmaceutical enterprise, engaged in the development, production, and marketing of both patented (branded) and generic drug formulations. Its commercial reach spans Australia, New Zealand, North America (covering the United States and Canada), Europe, and Asia. The company's op...
Where does MAYNF trade?
Mayne Pharma Group Limited (MAYNF) trades on the Other OTC.
What sector is MAYNF in?
Mayne Pharma Group Limited (MAYNF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Mayne Pharma Group Limited?
Aaron Gray is the chief executive officer of Mayne Pharma Group Limited (MAYNF).
Where is Mayne Pharma Group Limited headquartered?
Mayne Pharma Group Limited is headquartered in Australia.
Does MAYNF pay a dividend?
Mayne Pharma Group Limited (MAYNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MAYNF go public?
Mayne Pharma Group Limited (MAYNF) completed its initial public offering in 2013.